Strategies to Boost Life Science Business Growth

Laboratory products

Strategies to Boost Life Science Business Growth

04 May, 2010

Published over 16 years ago. See the latest and most current information on Laboratory products.

Bridge4Bio, an international business consultancy group focused on promoting the growth of life sciences and biotechnology companies, is targeting four strategic areas to assist both startups and established companies plan and grow their businesses globally. Bridge4Bio’s team of senior consultants addresses the following: Channel development - Bridge4Bio’s senior management team with its global coverage helps clients find the appropriate distributor, or choose appropriate partners for OEM mergers or licensing deals to expand their business.

Strategic marketing - Bridge4Bio provides guidance on how to build and implement a global business plan including developing new and existing product line channel strategies. Advice covers implementing market promotions and communication programmes, agreement negotiation, as well as ensuring IP and profitability are solid to capitalise on future opportunities. Global sourcing - Bridge4Bio’s international experience simplifies identifying the best sources to manufacture product, reduce cost, negotiate contracts, or improve quality through long-term global partnerships to gain a competitive advantage. Capital investment - Bridge4Bio is well connected to Silicon Valley and global investment contacts to act as a bridge between the client and an appropriate investor or partnership company.

“Forming a partnership with Bridge4Bio allows life sciences and biotechnology companies, both large and small, to maximise their growth potential while working with tight budgets,” explained Hugh Douglas, Bridge4Bio’s President. Douglas continued: “Bridge4Bio provides our clients the experience of a network of ten international life sciences and biotechnology consultants who have all experienced first-hand the start-up and growth challenges faced by life sciences and biotechnology businesses in global markets. We recognise that companies may not have the funds for high-priced consultants. The client pays us based on the success

of the implementation which means that the up-front cost and risk is further reduced for our clients.”

Latest News

ILM 51.5 July 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
New Ammonia technology offers exciting decarbonisation opportunity
Explore more Arrow
Pollution Solutions Online
Innovative landfill liner transforms sustainable drainage systems for Yorkshire flood resilience
Explore more Arrow
Petro Online
Digitalisation advances at a large petrochemical complex in China
Explore more Arrow
Chromatography Today
Affordable liquid chromatography solvent delivery pump
Explore more Arrow